Praxsyn Corporation Announces New Chief Financial Officer

IRVINE, Calif., July 27, 2015 (GLOBE NEWSWIRE) -- Praxsyn Corporation's (OTCQB:PXYN) today announced that Justin Cary, 33, has been appointed by the Board of Directors as the company's Chief Financial Officer (CFO) effective immediately.

Mr. Cary brings years of financial and accounting experience to his role at Praxsyn. His qualifications include expertise in SEC reporting, accounting clean-up, audit support, and efficiencies and process improvement. Mr. Cary was hired as Controller in April 2015. Prior to that he had been a consultant for Praxsyn and was instrumental in guiding the accounting team through its reverse merger, as well as providing SEC reporting services. Previous company experience included roles involved with lending services, corporate accounting and auditing with PriceWaterhouseCoopers. He also worked with NowCFO where he consulted with a variety of clients, in many industries, and gained invaluable public reporting experience.

"Justin's impressive background in SEC reporting is a perfect fit for Praxsyn's financial operations," said Edward Kurtz, CEO of Praxsyn Corporation. "I have complete confidence that Justin will bring fresh and innovative ideas to Praxsyn that will serve to continue improving our operating and financial efficiency and allow for improved shareholder value."

Mr. Cary earned his Bachelors and Master's of Science degrees in Accounting from Michigan State University. He also served as an enlisted reservist in the United States Army for six years.

The board of directors also unanimously resolved to remove the interim from the titles of Edward Kurtz, Chief Executive Officer and Kimberly Brooks, Secretary.

About Praxsyn Corporation

Headquartered in Irvine, California, Praxsyn works to realize the vision of medical professionals to improve the lives of patients. Mesa Pharmacy, a wholly owned subsidiary, provides doctors with an alternative to oral pain medications. Mesa focuses on providing custom compounded non-narcotic, transdermal topical pain medications that are marketed to industrial health physicians and medical clinics. Mesa has developed a series of topical creams, in different strengths, that provide the pain relief doctors seek for their patients. Additional company information can be found at

Forward-Looking Statements

Certain statements made in this press release are forward-looking in nature (within the meaning of the Private Securities Litigation Reform Act of 1995) including but not limited to statements regarding the past performance, expected cash on hand and anticipated results of announcement of Praxsyn's new Chief Financial Officer and, accordingly, are subject to risks and uncertainties. The actual results may differ materially from those described or contemplated and consequently, you should not rely on these forward-looking statements as predictions of future events. Certain of these risks and uncertainties are discussed in the reports we filed with the SEC.

CONTACT: Media/Investor Contact: 949-777-6112 ext 101

Source:Praxsyn Corporation